Browse the evidence

The article proposes measures to strengthen causal inference in dietary trials.

Implementing proposed measures could enhance the reliability of findings in dietary research.

The overall incidence of remissions per 1000 person-years was 10.5.

Practitioners should be aware of the remission rates in this population.

68% of the American population is overweight or obese.

Healthcare providers should be aware of the high prevalence of overweight and obesity in their patient population.

Federal leaders have called for the development of health promotion campaigns directed to low-income minority groups in the US.

Nutrition educators should focus on developing targeted health promotion campaigns for these populations.

Obesity prevalence is projected to grow by 40% in the next decade.

Health practitioners should prepare for increased obesity-related health issues.

The incidence of obesity-related glomerulopathy has increased 10-fold in recent years.

Increased awareness and screening for kidney issues in obese patients is essential.

Cardiovascular, renal, and metabolic diseases are leading global causes of death and are associated with substantial morbidity and mortality.

Healthcare providers should prioritize the management of these diseases due to their significant impact on mortality and morbidity.

CE/BZA resulted in a non-significant increase in resting metabolic rate (RMR).

There may be a slight increase in metabolic rate, but it is not statistically significant.

U.S. adults accumulate fewer steps per day than those living in Switzerland, Australia, and Japan.

This finding suggests a need for increased physical activity initiatives in the U.S.

Routine exclusion of evidence other than randomized controlled trials (RCTs) or meta-analyses from consideration in treatment may not always be wise.

Practitioners should consider a broader range of evidence when making treatment decisions.

Synthesis of data from various sources, including epidemiological studies, can improve patient care.

Integrating diverse research findings can lead to better treatment guidelines and patient discussions.

Chronic treatment of obese insulin-resistant wild-type animals with a long-acting GIPR agonist prevented rosiglitazone-induced weight gain and hyperphagia.

GIPR agonists may be beneficial in managing weight gain and overeating in insulin-resistant conditions.

The evolution of health information technologies has been documented through case studies, including type 2 diabetes.

Case studies can be used to illustrate the effectiveness of new health technologies.

The incidence of obesity-related glomerulopathy has increased 10-fold in recent years.

Increased awareness and screening for kidney issues in obese patients is necessary.

The changes made to our environment over the past several decades have facilitated weight gain and contributed to high rates of obesity.

Practitioners should consider environmental factors when addressing obesity.

Acute low-intensity resistance exercise with blood flow restriction (LIRE-BFR) may induce increases in central blood pressure and pulse wave velocity in healthy young people.

Practitioners should be aware that LIRE-BFR can lead to increased central blood pressure and arterial stiffness in young clients.

Dietary patterns intersect with psychosocial vulnerabilities linked to risks of antisocial behavior.

Understanding dietary influences can help address psychosocial issues related to antisocial behavior.

Obesity is a modern epidemic with substantial health and economic impact.

Recognize obesity as a critical public health issue requiring attention.

There was no significant change in diastolic blood pressure after 8 weeks of resistance training in both groups.

Practitioners should note that while systolic BP decreases, diastolic BP may not be affected by resistance training in this population.

Utilization of anti-obesity agents is rising in reproductive-age females planning for future pregnancy.

Practitioners should be aware of the increasing use of anti-obesity agents in this population.

The definitive role of assisting weight loss with medication prior to pregnancy remains to be established.

Further research is needed to clarify the role of anti-obesity medications in weight loss for women prior to pregnancy.

Clinicians are generally ill-equipped to advise patients on effective, longitudinal weight loss strategies.

There is a need for better tools and training for clinicians in weight loss strategies.

Central blood pressure (BP) correlates more with future cardiovascular risk than peripheral BP.

Practitioners should consider central BP measurements for assessing cardiovascular risk in obese patients.

There is no definitive evidence of causality between ultra-processed foods and adverse health outcomes.

Practitioners should be cautious in making definitive claims about UPFs and health outcomes.